Insights Into Atopic Dermatitis – From Pathogenesis to Therapy

1 Akdis CA, Akdis M, Bieber T, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol, 2006, 118:152-169. Search in Google Scholar

2 Illi S, von Mutius E, Lau S, et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol, 2004, 113:925-931. Search in Google Scholar

3 Silverberg JI. Atopic Dermatitis in Adults. Med Clin North Am. 2020 Jan; 104(1):157-176. doi: 10.1016/j.mcna.2019.08.009). Search in Google Scholar

4 Bieber T. Atopic Dermatitis. N Engl J Med, 2008, 358:1483-1494. Search in Google Scholar

5 Bhattacharya N, Sato WJ, Kelly A, et al. Epidermal Lipids: Key Mediators of Atopic Dermatitis Pathogenesis. Trends Mol Med, 2019, 25(6):551-562. https://doi.org/10.1016/j.molmed.2019.04.001 Search in Google Scholar

6 Schultz LF. Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol, 1993, 28(5 Pt 1):719–723. Search in Google Scholar

7 Rawlings AV, Harding CR. Moisturization and skin barrier function. Dermatol Ther, 2004, 17(Suppl 1):43–48. Search in Google Scholar

8 Kezic S, O’Regan GM, Lutter R, et al. Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency. J Allergy Clin Immunol, 2012, 129:1031-1039. Search in Google Scholar

9 Brauweiler AM, Bin L, Kim BE, et al. Filaggrin dependent secretion of sphingomyelinase protects against Staphylococcal alphatoxin-induced keratinocyte death. J Allergy Clin Immunol, 2013, 131:421-427. Search in Google Scholar

10 Silverberg JI. Atopic Dermatitis in Adults. Med Clin N Am, 2020, 104:157-176. https://doi.org/10.1016/j.mcna.2019.08.009 Search in Google Scholar

11 Mohiuddin M, Ramamoorthy P, Reynolds PR, et al. Increased compound heterozygous filaggrin mutations in severe atopic dermatitis in the United States. J Allergy Clin Immunol Pract, 2013, 1:534-536. Search in Google Scholar

12 Heine G, Hoefer N, Franke A, et al. Association of vitamin D receptor gene polymorphisms with severe atopic dermatitis in adults. Br J Dermatol, 2013, 168(4):855–858. Search in Google Scholar

13 Berker T, Visscher D, Gooris GS, et al. Topically applied ceramides interact with the stratum corneum lipid matrix in compromised ex vivo skin. Pharm Res, 2018, 35(3):48. doi: 10.1007/s11095-017-2288-y Search in Google Scholar

14 Schmid-Wendtner MH, Korting HC. The pH of the skin surface and its impact on the barrier function. Skin Pharmacol Physiol, 2006, 19:296-302. Search in Google Scholar

15 Schafer L, Kragballe K. Abnormalities in epidermal lipid metabolism in patients with atopic dermatitis. J Invest Dermatol, 1991, 96:10–15. Search in Google Scholar

16 McGirt LY, Beck LA. Innate immune defects in atopic dermatitis. J Allergy Clin Immunol, 2006, 118:202-208. Search in Google Scholar

17 Howell MD, Wollenberg A, Gallo RL, et al. Cathelicidin deficiency predisposes to eczema herpeticum. J Allergy Clin Immunol 2006;117: 836-41. Search in Google Scholar

18 Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science, 1996, 272:60-66. Search in Google Scholar

19 Picker LJ, Martin RJ, Trumble A, et al. Differential expression of lymphocyte homing receptors by human memory/effector T cells in pulmonary versus cutaneous immune effector sites. Eur J Immunol, 1994, 24:1269-1277. Search in Google Scholar

20 Novak N, Bieber T. Allergic and nonallergic forms of atopic diseases. J Allergy Clin Immunol, 2003, 112:252-262. Search in Google Scholar

21 Kerschenlohr K, Darsow U, Burgdorf WH, et al. Lessons from atopy patch testing in atopic dermatitis. Curr Allergy Asthma Rep, 2004, 4:285-289. Search in Google Scholar

22 Spergel JM, Mizoguchi E, Brewer JP, et al. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest, 1998, 101:1614-1622. Search in Google Scholar

23 Traidl-Hoffmann C, Mariani V, Hochrein H, et al. Pollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization. J Exp Med, 2005, 201:627-636. Search in Google Scholar

24 Clark RA, Chong B, Mirchandani N, et al. The vast majority of CLA+ T cells are resident in normal skin. J Immunol, 2006, 176:4431-4439. Search in Google Scholar

25 Soumelis V, Reche PA, Kanzler H, et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol, 2002, 3:673-680. Search in Google Scholar

26 Grewe M, Walther S, Gyufko K, et al. Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. J Invest Dermatol, 1995, 105:407-410. Search in Google Scholar

27 Tazawa T, Sugiura H, Sugiura Y, et al. Relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis. Arch Dermatol Res, 2004, 295(11):459–464. Search in Google Scholar

28 Trautmann A, Akdis M, Kleemann D, et al. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest, 2000, 106:25-35. Search in Google Scholar

29 Esaki H, Brunner PM, Renert-Yuval Y, et al. Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin. J Allergy Clin Immunol, 2016, 138(6):1639–1651. Search in Google Scholar

30 Aichberger KJ, Mittermann I, Reininger R, et al. Hom s 4, an IgE-reactive autoantigen belonging to a new subfamily of calcium-binding proteins, can induce Th cell type 1-mediated autoreactivity. J Immunol, 2005, 175:1286-1294. Search in Google Scholar

31 Leung DYM. Pathogenesis of atopic dermatitis. J Allergy Clin Immunol, 1999, 104 (Suppl):S99-108. Search in Google Scholar

32 Kramer MS, Kakuma R. Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child. Evid Based Child Health, 2014, 9:447–483. Search in Google Scholar

33 Khan A, Adalsteinsson J, Whitaker-Worth DL. Atopic dermatitis and nutrition. Clin Dermatol, 2022, 40(2):135-144. https://doi.org/10.1016/j.clindermatol.2021.10.006 Search in Google Scholar

34 Leung DYM, Guttman-Yassky E. Deciphering the complexities of atopic dermatitis: Shifting paradigms in treatment approaches. J Allergy Clin Immunol, 2014, 134(4):769-779. doi: 10.1016/j.jaci.2014.08.008 Search in Google Scholar

35 Lever R, Hadley K, Downey D, et al. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol, 1988, 119:189-198. Search in Google Scholar

36 Bunikowski R, Mielke M, Skarabis H, et al. Prevalence and role of serum IgE antibodies to the Staphylococcus aureus– derived superantigens SEA and SEB in children with atopic dermatitis. J Allergy Clin Immunol, 1999, 103:119-124. Search in Google Scholar

37 Nickoloff BJ, Naidu Y. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol, 1994, 30:535-546. Search in Google Scholar

38 Nakajima S, Igyarto BZ, Honda T, et al. Langerhans cells are critical in epicutaneous sensitization with protein antigen via thymic stromal lymphopoietin receptor signaling. J Allergy Clin Immunol, 2012, 129:1048-1055. Search in Google Scholar

39 Ghoreschi K, Laurence A, O’Shea JJ. Janus kinases in immune cell signaling. Immunol Rev, 2009, 228(1):273-287. Search in Google Scholar

40 Suga H, Sato S. Novel topical and systemic therapies in atopic dermatitis. Immunol Med, 2019, 42(2):84-93. Search in Google Scholar

41 Jimenez JL, Punzon C, Navarro J, et al. Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-kappa B and nuclear factor of activated T cells activation. J Pharmacol Exp Ther, 2001, 299(2):753-759. Search in Google Scholar

42 Grewe SR, Chan SC, Hanifin JM. Elevated leukocyte cyclic AMP-phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP-agonist hyporesponsiveness. J Allergy Clin Immunol, 1982, 70(6):452-457. Search in Google Scholar

43 Nakajima S, Igyarto BZ, Honda T, et al. Langerhans cells are critical in epicutaneous sensitization with protein antigen via thymic stromal lymphopoietin receptor signaling. J Allergy Clin Immunol, 2012, 129:1048-1055. Search in Google Scholar

44 Dominguez O, Plaza AM, Alvaro M. Relationship Between Atopic Dermatitis and Food Allergy. Curr Pediatr Rev. 2020;16(2):115-22. Search in Google Scholar

45 Kajosaari M. Atopy prophylaxis in high-risk infants. Prospective 5-year follow-up study of children with six months exclusive breastfeeding and solid food elimination. Adv Exp Med Biol, 1991, 310:453–458. Search in Google Scholar

46 Bergmann RL, Diepgen TL, Kuss O, et al. Breastfeeding duration is a risk factor for atopic eczema. Clin Exp Allergy, 2002; 32:205–209. Search in Google Scholar

47 Khan A, Adalsteinsson J, Whitaker-Worth DL. Atopic dermatitis and nutrition. Clin Dermatol, 2022, 40(2): 135-144. https://doi.org/10.1016/j.clindermatol.2021.10.006 Search in Google Scholar

48 Zhao M, Shen C, Ma L. Treatment efficacy of probiotics on atopic dermatitis, zooming in on infants: a systematic review and meta-analysis. Int J Dermatol, 2018, 57 :635–641. Search in Google Scholar

49 Pessi T, Sütas Y, Hurme M, et al. Interleukin-10 generation in atopic children following oral lactobacillus rhamnosus GG. Clin Exp Allergy, 2000, 30:1804–1808. Search in Google Scholar